Hey Duffy
Thanks for the read. I'll be 50/50 On-X verses St. Jude. I will get this report to my surgeon and HOPE that he reads it. Even St. Jude is anticipating that warfarin will be a thing of the past in 5 years.
St Jude folks feeling slanted by On-X propeganda, do a google search of the following, you will be pleasantly surprised.
Small aortic annulus: The hydrodynamic performances of 5
commercially available bileaflet mechanical valves
I have copied some of the finding below:
Small aortic annulus: The hydrodynamic performances of 5
commercially available bileaflet mechanical valves
Tomaso Bottio, MD
Luca Caprili, MD
Dino Casarotto, MD
Gino Gerosa, MD
The Journal of Thoracic and Cardiovascular Surgery ● Volume 128, Number 3
Results: The SJM Regent valve and the Sorin Bicarbon Slimline prosthesis showed
the lowest mean and peak gradients at increasing cardiac outputs. The closure
volume was higher for the SJM Regent and Sorin Bicarbon Slimline prostheses,
unlike with the ATS prosthesis at 7 L/min of cardiac output. The ATS and SJM
Regent prostheses showed the largest regurgitant volume, whereas the Sorin Bicar-
bon Slimline prosthesis showed the lowest regurgitant volume. The calculated
effective orifice area and stroke work loss were significantly better with the SJM
Regent and Sorin Bicarbon Slimline prostheses.
Conclusion: Assuming that the 21-mm valve holder in which all the tested pros-
theses were accommodated is comparable with a defined aortic valve size, this
hydrodynamic evaluation model allowed us to compare the efficiency of currently
available valve prostheses, and among these, the SJM Regent and the Sorin
Bicarbon Slimline exhibited the best performances.
These results are well explained for the SJM Regent
valve by using the evidence of the larger EOA, greater
geometric orifice area, and valve clear area when compared
with those values in the others prostheses. As previously
published, at 5 L/min of CO, the SJM Regent valve showed
the greatest closing volume, becoming comparable with the
others at 7 L/min. Nevertheless, among all tested valves, we
observed the lowest stroke work loss with the SJM Regent
valve. With the small valve size, the cause of energy loss
was largely the result of the forward flow transvalve pres-
sure difference, with less than 10% being the result of the
regurgitant flow,15 and these satisfactory results with the
SJM Regent depend mostly on the improved design and
increased geometric orifice area.
On the other hand, the results obtained with the On-X
valve are controversial and difficult to explain. In fact, the
On-X valve, which was designed to improve hydrodynamic
performance, unlike accredited of the largest clear orifice
area, the largest calculated EOA at lower CO, and the
greater opening angle (90°), showed results in terms of
regurgitant volumes, transprosthetic gradients, and stroke
work loss comparable with those of the Carbomedics Top
Hat and ATS valves and significantly inferior to those
obtained with the Sorin Bicarbon Slimline and SJM Regent
prostheses. Therefore further explanations, probably related
to the peculiar On-X prosthesis design (higher profile) or to
an incomplete valve opening, might be inferred.
In conclusion, according to our experimental model,
each of the tested valves could be accommodated on a
21-mm aortic annulus, but in the light of these in vitro
results, the best hemodynamic performances should be ob-
tained mostly with the SJM Regent and Sorin Bicarbon
Slimline prostheses.
This is for you Bina